| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |